CORONA — Corona Remedies Balance Sheet
0.000.00%
Last trade - 00:00- IN₹84.05bn
- IN₹84.06bn
- IN₹11.96bn
Annual balance sheet for Corona Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 827 | 699 | 719 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 874 | 1,003 | 1,187 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | 2,915 | 2,899 | 3,389 |
| Net Property, Plant And Equipment | 2,488 | 3,116 | 3,847 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 5,950 | 8,306 | 9,299 |
| Accounts Payable | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 1,374 | 2,242 | 2,396 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Total Other Liabilities | |||
| Total Liabilities | 1,865 | 3,502 | 3,235 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 4,085 | 4,804 | 6,063 |
| Total Liabilities & Shareholders' Equity | 5,950 | 8,306 | 9,299 |
| Total Common Shares Outstanding |